Prevalence of metabolic syndrome among patients with schizophrenia in Japan

Norio Sugawara, Norio Yasui‐Furukori, Yasushi Sato, +9

Schizophrenia Research

ObesityMetabolic SyndromeBody CompositionMetabolic DisorderPsychiatry +7

Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes

Norio Yasui‐Furukori, Takenori Takahata, Taku Nakagami, +4

British Journal of Clinical Pharmacology

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition

Taku Nakagami, Norio Yasui‐Furukori, Masako Saitō, +2

Clinical Pharmacology & Therapeutics

Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics

Akira Fujii, Norio Yasui‐Furukori, Norio Sugawara, +4

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Sexual HealthPsychiatryPsychotic DisorderPsychotropic MedicationSexual Dysfunction +4

Effects of various factors on steady‐state plasma concentrations of risperidone and 9‐hydroxyrisperidone: lack of impact of MDR‐1 genotypes

Norio Yasui‐Furukori, Kazuo Mihara, Takenori Takahata, +6

British Journal of Clinical Pharmacology

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan

Norio Sugawara, Kazuma Danjo, Hanako Furukori, +6

Neuropsychiatric Disease and Treatment

Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: A preliminary study

Norio Yasui‐Furukori, Manabu Saito, Taku Nakagami, +3

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Schizophrenic PatientsPsychiatryMedicinePsychotropic MedicationGenetic Epidemiology +10

Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients

Norio Yasui‐Furukori, Manabu Saito, Shoko Tsuchimine, +4

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Plasma ConcentrationsSchizophrenic PatientsPsychiatryPsychotic DisorderMedicine +11

Dose-Dependent Interaction of Paroxetine With Risperidone in Schizophrenic Patients

Manabu Saito, Norio Yasui‐Furukori, Taku Nakagami, +2

Journal of Clinical Psychopharmacology

Dose-dependent InteractionClinical SymptomsPsychotropic MedicationPsychopharmacologyPharmacotherapy +14

The influence of personality factors on paroxetine response time in patients with major depression

Ayako Kaneda, Norio Yasui‐Furukori, Taku Nakagami, +2

Journal of Affective Disorders

Personality FactorsPsychological Co-morbiditiesPsychopathologyPsychiatryMood Symptom +10